24th Nov 2005 16:00
AstraZeneca PLC24 November 2005 Companies Act 1985 Section 198 Disclosure of Interest in Voting Shares in Public Companies On 24 November 2005 we were informed by The Capital Group Companies, Inc., aregistered investment manager in the U.S., that on 22 November 2005 its interestin the USD0.25 Ordinary Shares of AstraZeneca PLC had increased to 195,493,748shares (12.30 per cent of the current issued ordinary capital) from thepreviously notified level of 191,743,910 shares (12.00 per cent of the issuedordinary capital at that time). The reason for this announcement is that,within the said holding of 12.30 per cent of the issued ordinary capital ofAstraZeneca PLC, Capital Research and Management Company, an affiliate of TheCapital Group Companies, Inc., has increased its interest in these shares to80,646,241 shares (5.07 per cent). G H R Musker Company Secretary 24 November 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca